Annual CFO
-$15.28 M
+$3.88 M+20.24%
December 31, 2023
Summary
- As of February 12, 2025, MTNB annual cash flow from operations is -$15.28 million, with the most recent change of +$3.88 million (+20.24%) on December 31, 2023.
- During the last 3 years, MTNB annual CFO has risen by +$2.09 million (+12.03%).
- MTNB annual CFO is now -411.35% below its all-time high of -$2.99 million, reached on December 31, 2013.
Performance
MTNB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.50 M
-$394.00 K-12.69%
September 30, 2024
Summary
- As of February 12, 2025, MTNB quarterly cash flow from operations is -$3.50 million, with the most recent change of -$394.00 thousand (-12.69%) on September 30, 2024.
- Over the past year, MTNB quarterly CFO has increased by +$919.00 thousand (+20.80%).
- MTNB quarterly CFO is now -2231.78% below its all-time high of -$150.10 thousand, reached on March 31, 2013.
Performance
MTNB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$16.95 M
+$919.00 K+5.14%
September 30, 2024
Summary
- As of February 12, 2025, MTNB TTM cash flow from operations is -$16.95 million, with the most recent change of +$919.00 thousand (+5.14%) on September 30, 2024.
- Over the past year, MTNB TTM CFO has dropped by -$1.96 million (-13.04%).
- MTNB TTM CFO is now -11195.14% below its all-time high of -$150.10 thousand, reached on March 31, 2013.
Performance
MTNB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MTNB Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.2% | +20.8% | -13.0% |
| 3 y3 years | +12.0% | +20.8% | -13.0% |
| 5 y5 years | -48.0% | +20.8% | -13.0% |
MTNB Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | +20.2% | -59.6% | +39.3% | -13.0% | +13.5% |
| 5 y | 5-year | -8.4% | +20.2% | -304.8% | +39.3% | -20.3% | +13.5% |
| alltime | all time | -411.4% | +20.2% | -2231.8% | +39.3% | <-9999.0% | +13.5% |
Matinas BioPharma Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.50 M(+12.7%) | -$16.95 M(-5.1%) |
| Jun 2024 | - | -$3.11 M(-46.2%) | -$17.87 M(+5.4%) |
| Mar 2024 | - | -$5.77 M(+26.0%) | -$16.96 M(+11.0%) |
| Dec 2023 | -$15.28 M(-20.2%) | -$4.58 M(+3.6%) | -$15.28 M(+1.9%) |
| Sep 2023 | - | -$4.42 M(+101.5%) | -$15.00 M(-3.5%) |
| Jun 2023 | - | -$2.19 M(-46.3%) | -$15.55 M(-15.9%) |
| Mar 2023 | - | -$4.09 M(-4.9%) | -$18.49 M(-3.5%) |
| Dec 2022 | -$19.16 M(+25.8%) | -$4.30 M(-13.5%) | -$19.16 M(+1.8%) |
| Sep 2022 | - | -$4.97 M(-3.1%) | -$18.81 M(-4.0%) |
| Jun 2022 | - | -$5.13 M(+7.9%) | -$19.59 M(+27.8%) |
| Mar 2022 | - | -$4.76 M(+20.2%) | -$15.33 M(+0.7%) |
| Dec 2021 | -$15.22 M(-12.3%) | -$3.96 M(-31.2%) | -$15.22 M(-2.2%) |
| Sep 2021 | - | -$5.75 M(+565.0%) | -$15.57 M(+3.5%) |
| Jun 2021 | - | -$864.70 K(-81.4%) | -$15.05 M(-13.3%) |
| Mar 2021 | - | -$4.65 M(+8.0%) | -$17.35 M(-0.1%) |
| Dec 2020 | -$17.37 M(+23.2%) | -$4.31 M(-17.6%) | -$17.37 M(-3.3%) |
| Sep 2020 | - | -$5.23 M(+64.9%) | -$17.96 M(+6.9%) |
| Jun 2020 | - | -$3.17 M(-32.1%) | -$16.81 M(+6.8%) |
| Mar 2020 | - | -$4.66 M(-4.8%) | -$15.73 M(+11.6%) |
| Dec 2019 | -$14.09 M(+36.5%) | -$4.90 M(+20.3%) | -$14.09 M(+19.3%) |
| Sep 2019 | - | -$4.07 M(+94.3%) | -$11.81 M(+13.8%) |
| Jun 2019 | - | -$2.10 M(-30.6%) | -$10.38 M(-1.5%) |
| Mar 2019 | - | -$3.02 M(+15.4%) | -$10.54 M(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$10.32 M(-9.9%) | -$2.62 M(-0.7%) | -$10.32 M(+7.3%) |
| Sep 2018 | - | -$2.64 M(+16.8%) | -$9.62 M(-1.5%) |
| Jun 2018 | - | -$2.26 M(-19.5%) | -$9.76 M(-13.1%) |
| Mar 2018 | - | -$2.81 M(+46.5%) | -$11.23 M(-2.0%) |
| Dec 2017 | -$11.46 M(+87.3%) | -$1.92 M(-31.2%) | -$11.46 M(-1.7%) |
| Sep 2017 | - | -$2.78 M(-25.3%) | -$11.66 M(+13.9%) |
| Jun 2017 | - | -$3.73 M(+23.0%) | -$10.24 M(+34.6%) |
| Mar 2017 | - | -$3.03 M(+43.3%) | -$7.61 M(+24.3%) |
| Dec 2016 | -$6.12 M(-21.7%) | -$2.12 M(+54.9%) | -$6.12 M(+19.5%) |
| Sep 2016 | - | -$1.37 M(+24.9%) | -$5.12 M(-13.4%) |
| Jun 2016 | - | -$1.09 M(-29.1%) | -$5.91 M(-16.0%) |
| Mar 2016 | - | -$1.54 M(+38.1%) | -$7.03 M(-10.0%) |
| Dec 2015 | -$7.81 M(-1.8%) | -$1.12 M(-48.3%) | -$7.81 M(-14.3%) |
| Sep 2015 | - | -$2.16 M(-2.6%) | -$9.11 M(+6.4%) |
| Jun 2015 | - | -$2.22 M(-4.6%) | -$8.57 M(+4.5%) |
| Mar 2015 | - | -$2.32 M(-3.9%) | -$8.20 M(+2.9%) |
| Dec 2014 | -$7.96 M(+166.5%) | -$2.42 M(+50.1%) | -$7.96 M(+10.4%) |
| Sep 2014 | - | -$1.61 M(-12.8%) | -$7.21 M(+11.1%) |
| Jun 2014 | - | -$1.85 M(-11.6%) | -$6.49 M(+31.7%) |
| Mar 2014 | - | -$2.09 M(+25.4%) | -$4.93 M(+64.9%) |
| Dec 2013 | -$2.99 M | -$1.67 M(+87.9%) | -$2.99 M(+126.1%) |
| Sep 2013 | - | -$887.00 K(+211.8%) | -$1.32 M(+204.1%) |
| Jun 2013 | - | -$284.50 K(+89.5%) | -$434.60 K(+189.5%) |
| Mar 2013 | - | -$150.10 K | -$150.10 K |
FAQ
- What is Matinas BioPharma Holdings annual cash flow from operations?
- What is the all time high annual CFO for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual CFO year-on-year change?
- What is Matinas BioPharma Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly CFO year-on-year change?
- What is Matinas BioPharma Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM CFO year-on-year change?
What is Matinas BioPharma Holdings annual cash flow from operations?
The current annual CFO of MTNB is -$15.28 M
What is the all time high annual CFO for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual cash flow from operations is -$2.99 M
What is Matinas BioPharma Holdings annual CFO year-on-year change?
Over the past year, MTNB annual cash flow from operations has changed by +$3.88 M (+20.24%)
What is Matinas BioPharma Holdings quarterly cash flow from operations?
The current quarterly CFO of MTNB is -$3.50 M
What is the all time high quarterly CFO for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly cash flow from operations is -$150.10 K
What is Matinas BioPharma Holdings quarterly CFO year-on-year change?
Over the past year, MTNB quarterly cash flow from operations has changed by +$919.00 K (+20.80%)
What is Matinas BioPharma Holdings TTM cash flow from operations?
The current TTM CFO of MTNB is -$16.95 M
What is the all time high TTM CFO for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM cash flow from operations is -$150.10 K
What is Matinas BioPharma Holdings TTM CFO year-on-year change?
Over the past year, MTNB TTM cash flow from operations has changed by -$1.96 M (-13.04%)